Evid Invest
Who owns DRUGWhat DRUG owns — n/a

Who owns BRIGHT MINDS BIOSCIENCES INC.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of DRUG from SEC Form 13F filings across 110 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 110 institutions disclosed 9.0M shares of BRIGHT MINDS BIOSCIENCES INC. worth $447.8M — about 130.7% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.

110

13F holders

$447.8M

value, 2026 filers

130.7%

of shares outstanding (9.0M sh)

19

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of DRUG's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Janus Henderson Group Ltd.NEW1.3M$67.0M0.0%19.6%new
2Cormorant Asset Management, LP800,000$39.9M2.7%11.6%-11.1%
3BlackRock, Inc.651,794$32.5M0.0%9.5%-5.0%
4Vestal Point Capital, LP545,000$27.2M0.7%7.9%0.0%
5BRAIDWELL LP483,822$24.1M1.0%7%0.0%
6Driehaus Capital Management LLC445,221$22.2M0.2%6.5%+2.7%
7Vivo Capital, LLC417,879$20.8M2.3%6.1%-25.0%
8Point72 Asset Management, L.P.372,481$18.6M0.0%5.4%+13.8%
9ADAGE CAPITAL PARTNERS GP, L.L.C.324,800$16.2M0.0%4.7%-3.0%
10Balyasny Asset Management L.P.304,561$15.2M0.0%4.4%-11.7%
11RA CAPITAL MANAGEMENT, L.P.265,000$13.2M0.1%3.9%0.0%
12DEERFIELD MANAGEMENT COMPANY, L.P.236,295$11.8M0.2%3.4%-16.5%
13WELLINGTON MANAGEMENT GROUP LLP221,361$11.0M0.0%3.2%+29.2%
14MPM BIOIMPACT LLC195,669$9.7M0.7%2.8%-3.2%
15Parkman Healthcare Partners LLC148,227$7.4M0.7%2.2%-27.7%
16GOLDMAN SACHS GROUP INC135,089$6.7M0.0%2%+1.0%
17EVENTIDE ASSET MANAGEMENT, LLC130,013$6.5M0.1%1.9%0.0%
18STATE STREET CORP122,150$6.1M0.0%1.8%0.0%
19GREAT POINT PARTNERS LLC109,603$5.5M1.3%1.6%0.0%
20GEODE CAPITAL MANAGEMENT, LLC104,059$5.2M0.0%1.5%-0.1%
21B Group, Inc.95,000$4.7M2.9%1.4%+40.7%
22ACUTA CAPITAL PARTNERS, LLC93,152$4.6M3.5%1.4%+0.4%
23Ikarian Capital, LLC88,951$4.4M0.4%1.3%0.0%
24MILLENNIUM MANAGEMENT LLC88,640$4.4M0.0%1.3%+32.8%
25MORGAN STANLEY87,809$4.4M0.0%1.3%+372.1%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.